Bromomethyl acetate → 5,6a(R),7,8,9,9a(S)-Hexahydro-2,5-dimethyl-3-[acetoxymethyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3H)-one

HRID 275330Notes

Reaction equation

HRID 275330 reaction equation
[CH3:1][C:2]1[NH:10][C:9]2[C:8](=[O:11])[N:7]([CH3:12])[C:6]3=[N:13][C@@H:14]4[CH2:18][CH2:17][CH2:16][C@@H:15]4[N:5]3[C:4]=2[N:3]=1.[C:19]([O:22][CH2:23]Br)(=[O:21])[CH3:20]>>[CH3:1][C:2]1[N:10]([CH2:23][O:22][C:19](=[O:21])[CH3:20])[C:9]2[C:8](=[O:11])[N:7]([CH3:12])[C:6]3=[N:13][C@@H:14]4[CH2:18][CH2:17][CH2:16][C@@H:15]4[N:5]3[C:4]=2[N:3]=1

Participants

3

Procedure

Treat 5,6a(R),7,8,9,9a(S)-hexahydro-2,5-dimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3H)-one from Example 19a with bromomethyl acetate in accordance with Example 47 to give the title compound as a powder.

Sources & evidence

ORD record
ord-b91dd292576a4b389e441bbb635cf326
Source dataset
uspto-grants-1995_02
Patent number
US05393755

Reaction notes

Loading…